drugset / Trial / NCT07036601
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the efficacy and safety of THDBH120 injection compared with placebo in weight reduction in overweight or obese subjects after 26 weeks of treatment.
Timeline
- Start
- 2025-01-06
- Primary completion
- 2026-02-13
- Completion
- 2026-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | THDBH120 | Unknown | — | Subcutaneous |